Overview
- 81 inspections across 80 sites are on record.
- 136 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-11-15.
At a glance
Inspections
81
Sites
80
Observations
136
Career since
Sep 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Eurofins BioPharma Product Testing Toronto, Inc. | 15 Nov 2023 | Human Drugs | |
| Teva Canada Limited | 10 Nov 2023 | Human Drugs | |
| B & J Group | 2 Oct 2023 | Animal Drugs & Feeds | View 483 → |
| Menasha Packaging Company LLC | 16 Aug 2023 | Human Drugs | |
| Carnegie Pharmaceuticals, LLC | 7 Jul 2023 | Human Drugs | View 483 → |
Sites inspected
Eurofins BioPharma Product Testing Toronto, Inc.North York, Canada1 insp.
Teva Canada LimitedScarborough, Canada1 insp.
B & J GroupMorrisville, United States1 insp.
Menasha Packaging Company LLCLebanon, United States1 insp.
Carnegie Pharmaceuticals, LLCDelran, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Deborah J Parris5 shared
Anastasia M Shields4 shared
Luis A Dasta3 shared
Sneha S Patel2 shared
Rajan Pragani2 shared
Marvin D Jones2 shared
Anita R Michael2 shared
Christina K Theodorou1 shared
Jaison J Eapen1 shared
Valerie L Whipp1 shared
Full investigator report
Get the verbatim findings behind Michael L Casner's 136 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site